Cargando…

Targeting the Metabolic Vulnerability of ARID1A-Deficient Hepatocellular Carcinoma

Detalles Bibliográficos
Autores principales:	Chan, For-Fan, Wong, Chun-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9254620/ https://www.ncbi.nlm.nih.gov/pubmed/35461795 http://dx.doi.org/10.1016/j.jcmgh.2022.03.010

Ejemplares similares

Targeting USP9X–AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma
por: Zhang, Feng-Kun, et al.
Publicado: (2022)

Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective
por: Lebedev, Timofey, et al.
Publicado: (2023)

Hepatocyte-Specific Arid1a Deficiency Initiates Mouse Steatohepatitis and Hepatocellular Carcinoma
por: Fang, Jia-Zhu, et al.
Publicado: (2015)

Targeting the TCA cycle through cuproptosis confers synthetic lethality on ARID1A-deficient hepatocellular carcinoma
por: Xing, Tao, et al.
Publicado: (2023)

ARID1B is a specific vulnerability in ARID1A-mutant cancers
por: Helming, Katherine C., et al.
Publicado: (2014)

ARID1A Deficiency Is Associated With High Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma
por: Iseda, Norifumi, et al.
Publicado: (2020)

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
por: Tenen, Daniel G, et al.
Publicado: (2020)

ZEB1 Fuels Serine Metabolism to Promote HCC Metastasis
por: Chan, For-Fan, et al.
Publicado: (2023)

Lipid Metabolism as a Targetable Metabolic Vulnerability in Colorectal Cancer
por: Zaytseva, Yekaterina
Publicado: (2021)

Selective vulnerability of ARID1A deficient colon cancer cells to combined radiation and ATR-inhibitor therapy
por: Xu, Shan, et al.
Publicado: (2022)

Targeting HSPA1A in ARID2-deficient lung adenocarcinoma
por: Wang, Xue, et al.
Publicado: (2021)

ARID2 Chromatin Remodeler in Hepatocellular Carcinoma
por: Loesch, Robin, et al.
Publicado: (2020)

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma
por: Meng, Guang-Xiao, et al.
Publicado: (2023)

Low ARID1A Expression is Associated with Poor Prognosis in Hepatocellular Carcinoma
por: Yim, Sun Young, et al.
Publicado: (2020)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Metabolic disease as a risk of hepatocellular carcinoma
por: Nishida, Naoshi
Publicado: (2021)

ARID1A: guardian of normal pancreatic ducts
por: Castellanos, Karla J., et al.
Publicado: (2019)

Metabolic Reprogramming and Vulnerabilities in Cancer
por: Lyssiotis, Costas A., et al.
Publicado: (2019)

ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma
por: Sato, Emi, et al.
Publicado: (2018)

Targeting Angiogenesis for Advanced Hepatocellular Carcinoma
por: Eso, Yuji
Publicado: (2020)

Habitat selection by vulnerable golden bandicoots in the arid zone
por: Lohr, Cheryl A., et al.
Publicado: (2021)

ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Feng, Yuanyuan, et al.
Publicado: (2022)

ARID1A‐deficient cells require HDAC6 for progression of endometrial carcinoma
por: Megino‐Luque, Cristina, et al.
Publicado: (2022)

Targeting the Vulnerabilities of Oncogene Activation
por: Huang, Christina, et al.
Publicado: (2023)

ARID2: A new tumor suppressor gene in hepatocellular carcinoma
por: Zhao, Hong, et al.
Publicado: (2011)

Metabolic vulnerabilities of MYC-induced cancer
por: Gouw, Arvin M., et al.
Publicado: (2016)

Clonality disguises the vulnerability of a threatened arid zone Acacia
por: Roberts, David G., et al.
Publicado: (2017)

ARID1A expression in hepatocellular carcinoma and relation to tumor recurrence after microwave ablation
por: Abdel-Moety, Aly, et al.
Publicado: (2022)

Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma
por: He, Fei, et al.
Publicado: (2015)

Effect of CRISPR Knockout of AXIN1 or ARID1A on Proliferation and Migration of Porcine Hepatocellular Carcinoma
por: Elkhadragy, Lobna, et al.
Publicado: (2022)

A metabolic vulnerability of small-cell lung cancer
por: Nomura, Miyuki, et al.
Publicado: (2018)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Loss of ARID1A Promotes Hepatocellular Carcinoma Progression via Up-regulation of MYC Transcription
por: Xiao, Yao, et al.
Publicado: (2021)

Nucleotide excision repair as a targetable vulnerability in leukemia
por: Lohmann, Gregor, et al.
Publicado: (2017)

Combined identification of ARID1A, CSMD1, and SENP3 as effective prognostic biomarkers for hepatocellular carcinoma
por: Zhao, Yuanyuan, et al.
Publicado: (2021)

The prime time for management of hepatocellular carcinoma in Hong Kong
por: Chan, Landon L., et al.
Publicado: (2023)

Therapeutic targeting of alternative splicing to inhibit hepatocellular carcinoma metastasis
por: Lee, Yun-Han
Publicado: (2022)

Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
por: Khare, Tripti, et al.
Publicado: (2017)

Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we
por: Tsoulfas, Georgios
Publicado: (2019)

Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
por: Du, Danyu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qjar6gnfqvqckav6vgoo8sjaoh